Mindmed announces exclusive license agreement with catalent for its patented zydis® fast-dissolve technology for use with mm-120

New york--(business wire)---- $mnmd--mindmed has entered into a license agreement to access catalent's proprietary zydis® orally disintegrating tablet (odt) technology.
MNMD Ratings Summary
MNMD Quant Ranking